Has Fernando Bianco, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,240,704 in general payments to Fernando Bianco, MD across 964 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Fernando Bianco, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Fernando Bianco, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Fernando Bianco, MD

Urology · Hialeah, FLNPI 1629169552

Payments from drug & device makers

$2,240,704in general payments, 2019–2025

Across 964 payments — averaging $2324.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Janssen Research & Development, LLC$894K
Merck$756K
Pfizer$255K
Clinical Laserthermia Systems Americas Inc.$164K
AstraZeneca$90K
Urovant Sciences Inc$25K
plus $55K from 52 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Janssen Research & Development, LLC	251	$894,441
Merck	21	$756,065
Pfizer	127	$255,419
Clinical Laserthermia Systems Americas Inc.	14	$164,183
AstraZeneca	13	$89,958
Urovant Sciences Inc	12	$25,282
Idorsia Pharmaceuticals US Inc	11	$20,124
Sumitomo Pharma America, Inc.	23	$10,127
Angiodynamics, Inc.	19	$7,165
Alnylam Pharmaceuticals Inc.	12	$5,035
Janssen Scientific Affairs, LLC	2	$2,110
Johnson & Johnson(3 entities)	156	$1,959
Astellas Pharma US Inc	73	$1,617
Intuitive Surgical	12	$1,178
Boston Scientific	21	$952
Tolmar Pharmaceuticals, Inc.	29	$596
AbbVie	23	$482
Rochester Medical Corporation	7	$393
EDAP Technomed Inc	2	$299
Bayer	16	$284
Coloplast	20	$244
Dendreon Pharmaceuticals LLC	10	$240
Endo Pharmaceuticals Inc.	10	$194
Ferring Pharmaceuticals Inc.	9	$194
Accord Healthcare, Inc.	1	$191
Teleflex LLC	2	$175
Telix Pharmaceuticals	8	$154
C. R. Bard, Inc. & Subsidiaries	4	$147
Blue Earth Diagnostics	4	$145
Myovant Sciences Inc.	5	$126
Neotract Inc.	1	$112
Isoray, Inc	2	$110
BK Medical Holding Company Inc.	2	$89
Verity Pharmaceuticals Inc.	4	$82
Antares Pharma, Inc.	4	$73
Profound Medical Corp.	1	$71
Sun Pharmaceutical Industries Inc.	3	$67
Myriad Genetic Laboratories, Inc.	3	$60
Procept Biorobotics Corporation	2	$58
Tolmar, Inc.	3	$55
Azurity Pharmaceuticals, Inc.	2	$42
Laborie Medical Technologies Corp.	1	$39
Axonics, Inc.	2	$38
Novartis	2	$38
Zyla Life Sciences, Inc.	2	$29
Analogic Corporation	1	$27
Progenics Pharmaceuticals, Inc.	1	$26
Acerus Pharmaceuticals Corporation	1	$26
Medtronic	1	$25
Integra Lifesciences Corporation	1	$25
Davol Inc.	1	$19
Immunitybio, Inc.	1	$18
Cook Medical LLC	1	$18
Clarus Therapeutics Inc.	1	$18
Urogen Pharma, Inc.	1	$16
Therapeuticsmd, Inc.	1	$15
Takeda Pharmaceuticals U.S.A., Inc.	1	$15
Novo Nordisk	1	$14

How this compares

$2,240,704 in reported general payments places this provider in the 95th percentile of 935 urology providers in Florida.

See all urology providers in Florida →

Medicare billing

Part B allowed, 2024

$184,257

Medicare patients

170

Services billed

1,343

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other urology in Hialeah

Edward GheilerHialeah$655K
Steven KesterPompano Beach$5.7M
Harvey SamowitzHallandale Beach$3.6M
Paul PeritoCoral Gables$3.6M
Graham GreeneLakeland$2.5M
Scott SellingerTallahassee$2.3M
Osvaldo PadronTampa$1.3M
Mark Anthony GonzalgoMiami$1.1M
Paul CrispenGainesville$1.1M
Craig HermanPompano Beach$1.1M

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →